Relmada Therapeutics, Inc. RLMD Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s convertible preferred stock authorized shares?
- Relmada Therapeutics, Inc. (RLMD) reported convertible preferred stock authorized shares of 200M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s convertible preferred stock authorized shares changed year-over-year?
- Relmada Therapeutics, Inc.'s convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 200M to 200M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s convertible preferred stock authorized shares?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 200M to 200M.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.